AAAAAA

   
Results: 1-3 |
Results: 3
Decreased nuclear factor-kappa B DNA binding activity following permanent focal cerebral ischaemia in the rat
Authors: Irving, EA Hadingham, SJ Roberts, J Gibbons, M Chabot-Fletcher, M Roshak, A Parsons, AA
Citation: Ea. Irving et al., Decreased nuclear factor-kappa B DNA binding activity following permanent focal cerebral ischaemia in the rat, NEUROSCI L, 288(1), 2000, pp. 45-48
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity
Authors: Sarau, HM Foley, JJ Schmidt, DB Martin, LD Webb, EF Tzimas, MN Breton, JJ Chabot-Fletcher, M Underwood, DC Hay, DWP Kingsbury, WD Chambers, PA Pendrak, I Jakas, DR Sathe, GM Van Horn, S Daines, RA Griswold, DE
Citation: Hm. Sarau et al., In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity, PROS LEUK E, 61(1), 1999, pp. 55-64
cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy
Authors: Anderson, KM Berrebi-Bertrand, I Kirkpatrick, RB McQueney, MS Underwood, DC Rouanet, S Chabot-Fletcher, M
Citation: Km. Anderson et al., cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy, J MOL CEL C, 31(4), 1999, pp. 705-719
Risultati: 1-3 |